Mr. Speaker, I listened with great interest to my colleague. I am very interested in this important vaccine. We do not know how effective it will be, but this could be a lifesaver for tens of thousands of people.
I would like to ask the member about the decision to sell the vaccine to NewLink Genetics for $200,000. That seems to be an absurdly low figure. We are also hearing questions raised about the ability of this company to deliver the vaccine. In fact, some international health organizations are calling on Canada to withdraw that agreement, which we have the right to do apparently.
Can my hon. colleague confirm whether that right exists to withdraw the rights by which this company was able to get the vaccine for such an outrageously low price, so we can get it to a larger company that can actually deliver the vaccine in a timely manner because we are potentially facing 10,000 new cases a week appearing in Africa?